Alain Merieux
Alain Mérieux is a French businessman, Chairman of Institut Mérieux.
- Alain Merieux is chairman of Institut Merieux, a medicine and public health conglomerate specializing in diagnostics, immunotherapy and nutrition.
- Alain’s grandfather, Marcel Merieux, founded the institute in 1897.
- Alain founded BioMerieux, one of the firm’s publicly traded arms, which specializes in diagnostic tests for infectious diseases such as tuberculosis.
- The firm’s other publicly-traded subsidiary, Transgene, develops vaccines to combat infectious diseases.
- Alain’s third son Alexandre, who shares the fortune, was named CEO of BioMerieux in 2014.
boardboardboardboardboardboardboardboardboardboardboardboardboardboardboardboardboardboardboardboardboardboardboardboardboardboardboardboardboardboardboardboardboardboardboardboardboardboardboardboardboardboardboardboardboardboardboardboardboardboardboardboardboardboardboardboardboardboardboardboardboardboardboardboardboardboardboardboardboardboardboardboardboardboardboardboardboardboardboardboardboardboardboardboardboardboardboardboardboardboardboardboardboardboardboardboardboardboardboardboardboardboardboardboardboardboardboardboardboardboardboardboardboardboardboardboardboardboardboardboardboardboardboardboardboardboardboard
